Autor/in Fallowfield, L 1 Gligorov, J 1 Jenkins, V 1 Lichinitser, M Machackova, Z 1 Müller, V 1 Osborne, S 1 Pivot, X 1 Sánchez Muñoz, A 1 Verma, S 1 alle zeigenListe einklappen
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study Pivot, X Verma, S Fallowfield, L Müller, V Lichinitser, M Jenkins, V Sánchez Muñoz, A 2017 - Forschungsinformationssystem des UKE
